Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin vs calcineurin inhibitors for secondary prevention of skin cancers in renal transplant recipients
2004-004947-23Phase 4Completed
- Sponsor
- UF de méthodologie en recherche clinique
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus in cutaneous squamous cell carcinoma (cSCC) (2 arms), sponsored by UF de méthodologie en recherche clinique. Primary endpoint: Annual incidence of cutaneous squamous cell carcinoma. Started Feb 2006; status: completed.
02
Drugs
sirolimus
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on 2004-004947-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004947-23.